The Preclinical CRO Market report points out national and global business prospects and competitive conditions for preclinical CRO. Market size estimation and forecasts were given based on a detailed research methodology tailored to the conditions of the demand for preclinical CRO. The preclinical CRO market has been segmented by services (bioanalysis & dmpk studies, toxicology testing), by end use (biopharmaceutical companies, medical device companies). Historical background for the demand of preclinical CRO has been studied according to organic and inorganic innovations in order to provide accurate estimates of the market size. Primary factors influencing the growth of the demand preclinical CRO have also been established with potential gravity. Major regions covered in the study include North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Market Segmentation:

By Services:   

• Bioanalysis & DMPK Studies
• Toxicology Testing

By End User:

• Biopharmaceutical Companies
• Medical Device Companies

By Region:

North America Preclinical CRO Market

• North America, by Country
  • US
  • Canada
  • Mexico
• North America, by Services
• North America, by Modality
• North America, by End User

Europe Preclinical CRO Market

• Europe, by Country
  • Germany
  • Russia
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Rest of Europe 
• Europe, by Services
• Europe, by Modality
• Europe, by End User

Asia Pacific Preclinical CRO Market

• Asia Pacific, by Country
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Rest of Asia Pacific 
• Asia Pacific, by Services
• Asia Pacific, by Modality
• Asia Pacific, by End User

Middle East & Africa Preclinical CRO Market

• Middle East & Africa, by Country 
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa
• Middle East & Africa, by Services
• Middle East & Africa, by Modality
• Middle East & Africa, by End User

South America Preclinical CRO Market

• South America, by Country 
  • Brazil
  • Argentina
  • Colombia
  • Rest of South America
• South America, by Services
• South America, by Modality
• South America, by End User

Major Companies: Envigo Corporation.; MPI research; Eurofins Scientific; PRA Health Sciences, Inc.; Wuxi AppTec; Medpace, Inc.; Pharmaceutical Product Development (PPD), LLC; PARAXEL International Corporation; ICON Plc; and Laboratory Corporation of America, Inc.

Years Covered in the Study:

Historic Year: 2017-2018

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2028

Objectives of this report:

• To estimate market size for preclinical CRO market on regional and global basis.
• To identify major segments in preclinical CRO market and evaluate their market shares and demand.
• To provide a competitive scenario for the preclinical CRO market with major developments observed by key companies in the historic years.
• To evaluate key factors governing the dynamics of preclinical CRO market with their potential gravity during the forecast period.

Reasons to Buy This Report:

• Provides niche insights for decision about every possible segment helping in strategic decision making process.
• Market size estimation of the preclinical CRO market on a regional and global basis.
• A unique research design for market size estimation and forecast.
• Identification of major companies operating in the market with related developments
• Exhaustive scope to cover all the possible segments helping every stakeholder in the preclinical CRO

Customization:

This study is customized to meet your specific requirements:

• By Segment
• By Sub-segment
• By Region/Country
• Product Specific Competitive Analysis

For more information, contact: [email protected]